The following is excerpted from the question-and-answer section of the transcript.
(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)
Question: Rohan Mandora - Equirus Securities Private Limited, Research Division - Analyst
: Congrats on the improved set of numbers. Sir, firstly, in terms of the upgrades that we have seen this quarter, if you can share some color on which
segments are they coming and when did this account slip?
Question: Rohan Mandora - Equirus Securities Private Limited, Research Division - Analyst
: And sir, secondly, on the PCR, despite we having contained provisioning line item for this quarter, we have not increased the PCR. It's showing on
the 50%, 51% mark. So will we remain comfortable at this level? Or over the next 2 years, we will see some increase on the PCR levels? And what
was the credit cost finance for FY '24?
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
OCTOBER 27, 2023 / 12:30PM, CTBK.NS - Q2 2024 City Union Bank Ltd Earnings Call
Question: Rohan Mandora - Equirus Securities Private Limited, Research Division - Analyst
: Got it, sir. And any specific number for credit cost guidance for this year?
Question: Rohan Mandora - Equirus Securities Private Limited, Research Division - Analyst
: And sir, lastly, there's been an increase in yield this quarter. So if you can just point here what was the benefit coming in from the interest reversals?
And was there any other reasons for the increase in the yields, yields on advances?
|
